Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells

European Journal of Cell Biology

Volumn 85, Issue 11, 2006, Pages 1189-1199

  Kwon, Dae Sik ^a   Kwon, Chae Hwa ^a   Kim, Jae Ho ^a   Woo, Jae Suk ^a   Jung, Jin Sup ^a   Kim, Yong Keun ^a  

^a Department of Physiology Medical Research Institute MRC for Ischemic Tissue Regeneration ^*  (South Korea)

Author keywords

Akt; EGFR; ERK; Hypoxia reoxygenation; Opossum kidney cells; Proliferation; Reactive oxygen species; XIAP

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; EPITHELIUM CELL; HYPOXIA; IN VITRO STUDY; KIDNEY CELL; KIDNEY ISCHEMIA; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REOXYGENATION; SIGNAL TRANSDUCTION; UPREGULATION;

DIDELPHIDAE;

EID: 33749670528     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2006.06.001     Document Type: Article

References (67)

1. Agazie Y., Ischenko I., and Hayman M. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene. Oncogene 21 (2002) 697-707
2. Andreucci M., Michael A., Kramers C., Park K.M., Chen A., Matthaeus T., Alessandrini A., Haq S., Force T., and Bonventre J.V. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int. 64 (2003) 1189-1198
3. Asanuma H., Torigoe T., Kamiguchi K., Hirohashi Y., Ohmura T., Hirata K., Sato M., and Sato N. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 65 (2005) 11018-11025
4. Bachmann S., Kriz W., Kuhn C., and Franke W.W. Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins. Histochemistry 77 (1983) 365-394
5. Bendinelli P., Piccoletti R., Maroni P., and Bernelli-Zazzera A. The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett. 398 (1996) 193-197
6. Budisavljevic M.N., Hodge L., Barber K., Fulmer J.R., Durazo-Arvizu R.A., Self S.E., Kuhlmann M., Raymond J.R., and Greene E.L. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am. J. Physiol. 285 (2003) F1138-F1148
7. Cai Z., and Semenza G.L. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109 (2004) 2050-2053
8. Cao C.C., Ding X.Q., Ou Z.L., Liu C.F., Li P., Wang L., and Zhu C.F. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 65 (2004) 834-845
9. Carter B.Z., Milella M., Altieri D.C., and Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97 (2001) 2784-2790
10. Chen E.Y., Mazure N.M., Cooper J.A., and Giaccia A.J. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res. 61 (2001) 2429-2433
11. Cobb M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71 (1999) 479-500
12. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335 (1998) 1-13
13. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256 (2000) 34-41
14. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
15. di Mari J.F., Davis R., and Safirstein R.L. MAPK activation determines renal epithelial cell survival during oxidative injury. Am. J. Physiol. 277 (1999) F195-F203
16. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
17. Finn W.F., and Chevalier R.L. Recovery from postischemic acute renal failure in the rat. Kidney Int. 16 (1979) 113-123
18. Franke T.F., Kaplan D.R., and Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88 (1997) 435-437
19. Gardai S.J., Whitlock B.B., Xiao Y.Q., Bratton D.B., and Henson P.M. Oxidants inhibit ERK/MAPK and prevent its ability to delay neutrophil apoptosis downstream of mitochondrial changes and at the level of XIAP. J. Biol. Chem. 279 (2004) 44695-44703
20. Gingery A., Bradley E., Shaw A., and Oursler M.J. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J. Cell. Biochem. 89 (2003) 165-179
21. Goldkorn T., Balaban N., Matsukuma K., Chea V., Gould R., Last J., Chan C., and Chavez C. EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress. Am. J. Respir. Cell Mol. Biol. 19 (1998) 786-798
22. Grone H.J., Weber K., Grone E., Helmchen U., and Osborn M. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am. J. Pathol. 129 (1987) 1-8
23. Guijarro C., and Egido J. Transcription factor-kappaB (NF-kappaB) and renal disease. Kidney Int. 59 (2001) 415-424
24. Guyton K.Z., Liu Y., Gorospe M., Xu Q., and Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2: role in cell survival following oxidant injury. J. Biol. Chem. 271 (1996) 4138-4142
25. Havens C.G., Ho A., Yoshioka N., and Dowdy S.F. Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen species. Mol. Cell. Biol. 26 (2006) 4701-4711
26. Holthofer H., Miettinen A., Lehto V.P., Lehtonen E., and Virtanen I. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab. Invest. 50 (1984) 552-559
27. Hu P., Han Z., Couvillon A.D., and Exton J.H. Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279 (2004) 49420-49429
28. Ichimura T., Maier J.A., Maciag T., Zhang G., and Stevens J.L. FGF-1 in normal and regenerating kidney: expression in mononuclear, interstitial, and regenerating epithelial cells. Am. J. Physiol. 269 (1995) F653-F662
29. Jones R.G., Parsons M., Bonnard M., Chan V.S., Yeh W.C., Woodgett J.R., and Ohashi P.S. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191 (2000) 1721-1734
30. Kandel E.S., and Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253 (1999) 210-229
31. Lederer E.D., Sohi S.S., and McLeish K.R. Parathyroid hormone stimulates extracellular signal-regulated kinase (ERK) activity through two independent signal transduction pathways: role of ERK in sodium-phosphate cotransport. J. Am. Soc. Nephrol. 11 (2000) 222-231
32. Lee Jr. J.T., and McCubrey J.A. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16 (2002) 486-507
33. Liston P., Young S.S., Mackenzie A.E., and Korneluk R.G. Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2 (1997) 423-441
34. Lo L.W., Cheng J.J., Chiu J.J., Wung B.S., Liu Y.C., and Wang D.L. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway. J. Cell Physiol. 188 (2001) 304-312
35. Madge L.A., and Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J. Biol. Chem. 275 (2000) 15458-15465
36. Moelling K., Schad K., Bosse M., Zimmermann S., and Schweneker M. Regulation of Raf-Akt cross-talk. J. Biol. Chem. 277 (2002) 31099-31106
37. Muller C., Dunschede F., Koch E., Vollmar A.M., and Kiemer A.K. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am. J. Physiol. 285 (2003) G769-G778
38. Nadasdy T., Laszik Z., Blick K.E., Johnson L.D., and Silva F.G. Proliferative activity of intrinsic cell populations in the normal human kidney. J. Am. Soc. Nephrol. 4 (1994) 2032-2039
39. Nony P.A., and Schnellmann R.G. Mechanisms of renal cell repair and regeneration after acute renal failure. J. Pharmacol. Exp. Ther. 304 (2003) 905-912
40. Nosaka Y., Arai A., Kanda E., Akasaki T., Sumimoto H., Miyasaka N., and Miura O. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk. Biochem. Biophys. Res. Commun. 285 (2001) 675-679
41. Nouwen E.J., Verstrepen W.A., Buyssens N., Zhu M.Q., and De Broe M.E. Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab. Invest. 70 (1994) 479-493
42. Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K., Tsukamoto Y., Ishibashi-Ueda H., Miwa S., Tambara K., Toyokuni S., Yutani C., and Kangawa K. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109 (2004) 242-248
43. Ouellette A.J., Malt R.A., Sukhatme V.P., and Bonventre J.V. Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J. Clin. Invest. 85 (1990) 766-771
44. Park K.M., Chen A., and Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 276 (2001) 11870-11876
45. Park K.M., Kramers C., Vayssier-Taussat M., Chen A., and Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J. Biol. Chem. 277 (2002) 2040-2049
46. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
47. Prenzel N., Fischer O.M., Streit S., Hart S., and Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Cancer 8 (2001) 11-31
48. Reddy S.A., Huang J.H., and Liao W.S. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J. Immunol. 164 (2000) 1355-1363
49. Romashkova J.A., and Makarov S.S. NF-kappaB is a target of Akt in anti-apoptotic PDGF signalling. Nature 401 (1999) 86-90
50. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., and Glass D.J. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286 (1999) 1738-1741
51. Safirstein R., DiMari J., Megyesi J., and Price P. Mechanisms of renal repair and survival following acute injury. Semin. Nephrol. 18 (1998) 519-522
52. Sato K., Sato A., Aoto M., and Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 215 (1995) 1078-1087
53. Sharples E.J., Patel N., Brown P., Stewart K., Mota-Philipe H., Sheaff M., Kieswich J., Allen D., Harwood S., Raftery M., Thiemermann C., and Yaqoob M.M. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 15 (2004) 2115-2124
54. Shimamura H., Terada Y., Okado T., Tanaka H., Inoshita S., and Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J. Am. Soc. Nephrol. 14 (2003) 1427-1434
55. Siegelin M.D., Kossatz L.S., Winckler J., and Rami A. Regulation of XIAP and Smac/DIABLO in the rat hippocampus following transient forebrain ischemia. Neurochem. Int. 46 (2005) 41-51
56. Sturrock A., Cahill B., Norman K., Huecksteadt T.P., Hill K., Sanders K., Karwande S.V., Stringham J.C., Bull D.A., Gleich M., Kennedy T.P., and Hoidal J.R. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. 290 (2006) L661-L673
57. Sui L., Dong Y., Watanabe Y., Yamaguchi F., Sugimoto K., and Tokuda M. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors. Oncol. Rep. 15 (2006) 773-778
58. Toback F.G. Regeneration after acute tubular necrosis. Kidney Int. 41 (1992) 226-246
59. Trapp T., Korhonen L., Besselmann M., Martinez R., Mercer E.A., and Lindholm D. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol. Cell. Neurosci. 23 (2003) 302-313
60. Wallin A., Zhang G., Jones T.W., Jaken S., and Stevens J.L. Mechanism of the nephrogenic repair response. Studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl-l-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab. Invest. 66 (1992) 474-484
61. Wang X., McCullough K.D., Franke T.F., and Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275 (2000) 14624-14631
62. Witzgall R., Brown D., Schwarz C., and Bonventre J.V. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney: evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J. Clin. Invest. 93 (1994) 2175-2188
63. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
64. Zhang J., Jin N., Liu Y., and Rhoades R.A. Hydrogen peroxide stimulates extracellular signal-regulated protein kinases in pulmonary arterial smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 19 (1998) 324-332
65. Zhang P., Wang Y.Z., Kagan E., and Bonner J.C. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J. Biol. Chem. 275 (2000) 22479-22486
66. Zhu Y., Culmsee C., Klumpp S., and Krieglstein J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1, 2 signaling pathways. Neuroscience 123 (2004) 897-906
67. Zhuang S., and Schnellmann R.G. H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells. Am. J. Physiol. 286 (2004) F858-F865